Vertex Inc. logo

Vertex Inc. (VERX)

Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
19. 91
+0.02
+0.08%
$
3.14B Market Cap
- P/E Ratio
0% Div Yield
624,829 Volume
0.38 Eps
$ 19.9
Previous Close
Day Range
19.81 20.03
Year Range
18.54 60.71
Want to track VERX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days

Summary

VERX closed today higher at $19.91, an increase of 0.08% from yesterday's close, completing a monthly increase of 4.49% or $0.86. Over the past 12 months, VERX stock lost -62.95%.
VERX is not paying dividends to its shareholders.
The last earnings report, released on Nov 05, 2025, exceeded the consensus estimates by 0.02%. On average, the company has fell short of earnings expectations by -0.05%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

VERX Chart

Similar

Appfolio Inc.
$ 231.39
+0.7%
SiTime Corporation
$ 362.04
-6.11%
GDS
GDS Holdings Ltd. - ADR
$ 36.27
+0.33%
SoundHound AI, Inc.
$ 4.98
-3.3%
SoundHound AI Inc.
$ 11.65
-3.12%
Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?

Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?

VRTX rises 9.2% in three months but trails its industry as mixed new-drug sales and tightened 2025 guidance cloud near-term momentum.

Zacks | 1 week ago
Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant "Strong Buy"

Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant "Strong Buy"

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities across its pipeline. JOURNAVX drives revenue with strong acute pain demand and is advancing into diabetic peripheral neuropathy (DPN) with two phase 3 studies enrolling through 2026. VRTX's BAFF/APRIL inhibitor povetacicept offers a 'pipeline in a pill' approach, targeting IgA Nephropathy and Primary Membranous Neuropathy, with key catalysts ahead and possible expansion opportunities.

Seekingalpha | 1 month ago
Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

VRTX tops Q3 earnings and revenue estimates on strong Trikafta and Alyftrek sales, but shares slip as Casgevy sales disappoint.

Zacks | 1 month ago

Vertex Inc. (VERX) FAQ

What is the stock price today?

The current price is $19.91.

On which exchange is it traded?

Vertex Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is VERX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 3.14B.

What is the earnings per share?

The EPS is 0.17.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Vertex Inc. ever had a stock split?

No, there has never been a stock split.

Vertex Inc. Profile

Software Industry
Information Technology Sector
Christopher David Young CEO
NASDAQ (NMS) Exchange
92538J106 CUSIP
US Country
1,900 Employees
- Last Dividend
- Last Split
29 Jul 2020 IPO Date

Overview

Vertex, Inc., established in 1978 and based in King of Prussia, Pennsylvania, operates internationally, offering cutting-edge tax technology solutions tailored for the retail trade, wholesale trade, and manufacturing industries. The company specializes in helping enterprises navigate the complex landscape of tax determination, compliance, reporting, and data management through a suite of products and services delivered both as traditional software licenses and modern Software as a Service (SaaS) subscriptions. With a focus on innovation, Vertex, Inc. leverages its extensive experience and industry-specific insights to provide comprehensive tax technology solutions designed to meet the evolving needs of its global clientele.

Products and Services

  • Tax Determination - Vertex provides advanced solutions for accurate tax determination, ensuring compliance with local, state, and international tax regulations.
  • Compliance and Reporting - This service encompasses workflow management tools, role-based security, and event logging to streamline tax compliance and reporting processes.
  • Tax Data Management - Aims to efficiently manage and organize tax-related data, allowing for enhanced accuracy and accessibility.
  • Document Management - Offers solutions for the secure storage, retrieval, and management of tax documents, facilitating easier audit and compliance.
  • Analytics and Insights - Provides analytical tools and insights to help businesses make informed decisions based on their tax data.
  • Pre-built Integration - Includes mapping data fields, business logic, and configurations for seamless integration with existing business systems.
  • Industry-specific Solutions - Tailored solutions designed to meet the unique tax challenges of various industries.
  • Technology Specific Solutions - Includes offerings like chain flow accelerator and SAP-specific tools to enhance tax processing for businesses utilizing specific technologies.
  • Implementation Services - Vertex offers configuration, data migration, implementation support, and training to ensure successful software deployment.
  • Managed Services - This comprehensive service includes tax return preparation, filing, tax payment, and notice management, allowing businesses to outsource their tax management.

Contact Information

Address: 2301 Renaissance Boulevard
Phone: 800 355 3500